Visit Bio-Rad at AMP 2026
Explore Bio-Rad solutions for molecular testing for oncology research at AMP 2026. From biomarker detection to MRD research, discover liquid biopsy technologies designed to help laboratories get more data from limited samples and streamline oncology research workflows.
Stop by booth 537 to connect with our experts and explore solutions including:
- QX700™ Droplet Digital™ PCR (ddPCR™) Systems
- QX600™ ddPCR System
- CFX Opus Dx Real-Time PCR Detection Systems for In Vitro Diagnostics
- Genesis Cell Isolation System
- New ddPLEX CrystalTag ddPCR Assays and advanced multiplexing solutions
Corporate Workshop
Wednesday
8:00 - 8:50 AM (PST)
MRD Detection & Monitoring in Solid Tumors and Heme Malignancies Using Personalized Tumor-Informed Droplet Digital PCR (ddPCR) Assays in Research Settings
Minimal residual disease (MRD) is an important area of oncology research, creating a need for highly sensitive approaches to detect low-abundance disease-associated variants. This workshop will explore the use of personalized, tumor-informed Droplet Digital PCR (ddPCR) assays for MRD research across hematologic malignancies and solid tumors. Leading researchers will discuss the need for highly sensitive MRD approaches, the development of whole-genome sequencing (WGS)-informed assays, and emerging research on personalized MRD assessment. Attendees will gain insights into assay design, analytical performance, workflow considerations, and the growing role of ddPCR technology in precision oncology research.
Location: Tahoma 3, Level 3, Arch at 800 Pike
Speakers
-
Image
Christopher Hourigan DM, DPhil, FRCP
Director, Virginia Tech FBRI Cancer Research Center -
Image
Laura Dillon, PhD, FACMG
Research Associate Professor, Fralin Biomedical Research Institute at Virginia Tech -
Image
William A. LaFramboise, PhD
Professor & Chief Genomics Technology Officer, Allegheny Cancer Institute -
Image
Prithwish Pal, PhD
Director, Global Product Marketing, Oncology Bio-Rad Laboratories
Innovation Spotlight
Thursday
6:15 - 6:45 PM (PST)
Unlocking More from Every Sample: New Multiplex Oncology Assays and Emerging MRD Applications with the QX700 ddPCR System*
Explore Bio-Rad's newest oncology assay portfolio for the QX700 ddPCR System and discover how advanced multiplexing and streamlined workflows are enabling laboratories to extract more information from limited samples while improving efficiency.
Bio-Rad product managers will highlight recently launched assays, share approaches for expanding biomarker coverage without adding complexity, and discuss how ddPCR technology is helping advance precision oncology research. The session will also examine emerging applications in minimal residual disease (MRD) detection and disease monitoring research, showcasing how highly sensitive molecular analysis can support the next generation of oncology testing and translational research.
Location: Innovation Spotlight Stage #2
*For Research Use Only. Not for use in diagnostic procedures.
Speakers
-
Image
Prithwish Pal, PhD
Director, Global Product Marketing, Oncology Bio-Rad Laboratories -
Image
Claudia Labrador Rached
Global Product Manager, Reagents and Assays Bio-Rad Laboratories
Poster Presentation
Saturday
9:15 - 10:15 AM (PST)
Multiplex Detection of HOXA9 Methylation and KRAS Mutations Using MSRE and ddPCR in Lung Cancer Plasma Samples
Poster G061 | Category: Genetics
Expo Hall
Authors:
Francisco Bizouarn1, Rikke F Andersen2, Eddy vanCollenburg1 and Nish Kumar1
Affiliation:
1. Bio-Rad Laboratories, Digital Biology Group, 5667 Gibraltar Drive, Pleasanton CA 94588
2. Department of Biochemistry, Vejle University Hospital, Vejle, Denmark.